NCT03879811

Determining the Effects of Temozolomide Followed by Nivolumab in Patients With Colorectal Cancer

Public trial-level signal summary for this oncology Phase 2 record.

Record overview

Status and phase

Status: WITHDRAWN

Phase: PHASE2

Sponsor: Memorial Sloan Kettering Cancer Center

Condition: Colorectal Cancer

Signal summary

Status signal: Registry Stop Signal

Timeline signals: stale_update_signal

Results signal: Low Signal

Operational burden: None

Stopped reason

No accrual